These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Cell adhesion molecules and pharmacologic applications. Round Table No 3 at Giens XIII]. McGregor J; Berdeaux A; Bonnet J; Cambien F; Fitzgerald D; Lacolley P; Lu H; Le Saux Narjoz A; Miossec P; Netter P; Poston R; Laurent S Therapie; 1998; 53(4):371-9. PubMed ID: 9806007 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular pharmacology and experimental therapeutics of taurine and related compounds. Giotti A Adv Exp Med Biol; 1987; 217():3-22. PubMed ID: 3324672 [No Abstract] [Full Text] [Related]
24. The role of the apelinergic and vasopressinergic systems in the regulation of the cardiovascular system and the pathogenesis of cardiovascular disease. Czarzasta K; Cudnoch-Jedrzejewska A Kardiol Pol; 2014; 72(2):122-5. PubMed ID: 24604503 [TBL] [Abstract][Full Text] [Related]
25. Abstracts of the 11th International Congress on Cardiovascular Pharmacotherapy. Montreal, Canada, 18-21 May 2002. Cardiovasc Drugs Ther; 2002; 16 Suppl 1():5-116. PubMed ID: 12108434 [No Abstract] [Full Text] [Related]
26. Abstracts of the 12th International Congress on Cardiovascular Pharmacotherapy. May 7-10, 2003. Barcelona, Spain. Cardiovasc Drugs Ther; 2003; 17(5-6):481-504. PubMed ID: 15318397 [No Abstract] [Full Text] [Related]
28. [Current concepts of the origin of circadian changes in the cardiovascular system under normal and pathological conditions]. Arushanyan EB Klin Med (Mosk); 2012; 90(4):11-7. PubMed ID: 22896973 [TBL] [Abstract][Full Text] [Related]
29. Molecular adhesion phenomena: ligands, receptors, protein domains and motifs. Soria M Boll Ist Sieroter Milan; 1989; 68(3):206-13. PubMed ID: 2491428 [No Abstract] [Full Text] [Related]
30. Introduction: adhesion molecules in cancer. Part I. Akiyama SK; Yamada KM Semin Cancer Biol; 1993 Aug; 4(4):215-8. PubMed ID: 8400143 [No Abstract] [Full Text] [Related]
31. [Function of the fasciclin I family]. Kii I; Kudo A Seikagaku; 2006 Jan; 78(1):16-26. PubMed ID: 16491908 [No Abstract] [Full Text] [Related]
32. 7th International Congress of Pharmacology: satellite symposium on chronopharmacology, Paris, 22-24 July, 1978. Partial list of abstracts. Chronobiologia; 1978; 5(2):175-217. PubMed ID: 28217 [No Abstract] [Full Text] [Related]
33. 7th International Symposium on Cardiovascular Pharmacotherapy. Jerusalem, Israel, June 1-5, 1997. Abstracts. Cardiovasc Drugs Ther; 1997 Jun; 11 Suppl 2():315-421. PubMed ID: 9255319 [No Abstract] [Full Text] [Related]
34. 5th International Symposium on Cardiovascular Pharmacotherapy. August 16-20, 1993. Abstracts. Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 2():397-478. PubMed ID: 8105879 [No Abstract] [Full Text] [Related]
35. [The pharmacology of eledoisin, physalaemin and their synthetic analogs--an example for the study of structure-effect relationships of peptides. II]. Stopp G; Niedrich H Z Arztl Fortbild (Jena); 1967 Apr; 61(7):359-71. PubMed ID: 5592652 [No Abstract] [Full Text] [Related]
36. [Joint position statement of Polish Gynecologic Society, Polish Cardiological Society, and Polish Menopause and Andropause Society on the effect of hormone replacement therapy on cardiovascular system]. Kornacewicz-Jach Z; Czarnecka D; Rynkiewicz A; Kotarski J; Paszkowski T; Pertyński T; Debski R; Wielgoś M Kardiol Pol; 2009 Jan; 67(1):72-6. PubMed ID: 19253195 [No Abstract] [Full Text] [Related]